SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotransplant(BTRN)
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
1475 39 0 BTRN
Emcee:  trevor john wilkinson Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
875How about "In my humiliated opinion" That’s how I feel for not sellingMark Bong-3/28/2001
874OT - BWDIK... I like it. WRT the H in IMHO being "honest": what elsHarold Engstrom-3/28/2001
873<i>but Nigel, are Brits humble?</i> If their portfolios have perfornigel bates-3/28/2001
872IMHO In my honest opinion I usually mean this, as I don't feel that there aMark Bong-3/28/2001
871(OT, & IMVHO) Oh, I don't know. IMO/IMHO usually carries the same weighnigel bates-3/28/2001
870OT silly rant: "IMHO" and "IMO". Give me a break! First oHarold Engstrom-3/28/2001
869Looks to me like they are projecting fairly significant Eligix revenues in the 2Biomaven-3/27/2001
868GAITHERSBURG, Md., March 26 /PRNewswire/ -- MedImmune, Inc. (Nasdaq: MEDI) annouMark Bong-3/27/2001
867The burn rate will be increased. But the estimated cost to develop and commerciaMark Bong-3/26/2001
866Public Broadcasting's Frontline will commence a two-part series on xenotransD.Lu-3/26/2001
865Its apparent that the Eligix acquisition will significantly increase the burn: TSpekulatius-3/26/2001
864<i>and treatments for cancer and inflammatory disorders.</i> www2.mscaram(o)uche-3/22/2001
863perhaps supportive of the Eligix anti-CD8 device....... Wednesday March 21, 5:1scaram(o)uche-3/21/2001
862Xenotransplantation article: accessatlanta.comRobert S.-3/18/2001
861Friday March 16, 8:03 am Eastern Time Press Release SOURCE: Genzyme General Gscaram(o)uche-3/16/2001
860Biotech firms face financial crunch Bear market hurts already struggling smallMark Bong-3/14/2001
859<i>I doubt that MEDI is playing that game</i> I was (kind of) jokingnigel bates-3/13/2001
858Nigel, I doubt that MEDI is playing that game, but the thought did cross my mindMark Bong-3/13/2001
857Irrespective of management naivete, $40m is an absurd value to put on the compannigel bates-3/13/2001
856"We've got our tail between our legs, and it's hard to run hard butscaram(o)uche-3/13/2001
855Message 15493074 `We believe that 2001 will be an exciting time for the advancemnigel bates-3/13/2001
854<i>Bottom line....... there's more dilution coming than was necessary&nigel bates-3/13/2001
853Described in the thread......... the last two offerings for BTRN were poorly scaram(o)uche-3/12/2001
852<< Management is actively pursuing various alternatives for raising capitaSpekulatius-3/12/2001
851CHARLESTOWN, Mass., March 12 /PRNewswire/ -- BioTransplant Incorporated (Nasdaq:nigel bates-3/12/2001
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News